Form D · Other Investment Fund

HCM Cure III LLC

New York, NY · CIK 0001787420

Offering snapshot reported Sep 6, 2019 · SEC filing

Reported sold: $8.28M
Investors reported: 36
Minimum accepted: $1
First sale: Aug 23, 2019

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 6, 2019	Initial	$8,275,000	No comparison	36	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-348216

Source: Form D, filed Sep 6, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

HCM CURE III, LLC

Investment adviser: HIGHLINE CAPITAL MANAGEMENT, L.P.

Gross asset value: $735K
Beneficial owners: 37
ADV minimum commitment: $0

Reported in Form ADV on Dec 9, 2022. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator MORGAN STANLEY FUND SERVICES USA, L.L.C. PURCHASE, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG NEW YORK, New York, United States

Custodian MORGAN STANLEY & CO. LLC NEW YORK, New York, United States Related to adviser: No

Prime broker MORGAN STANLEY & CO. LLC NEW YORK, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG
PCAOB 185

MORGAN STANLEY & CO. LLC
SEC 8-15869

MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869

Filing source

Form ADV 1691500 · Dec 9, 2022 · Schedule D 7.B.(1), fund 805-9918322436

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Jacob W. Doft	Director, Executive
N/A Highline Capital Gp, Inc.	Director, Executive
N/A Highline Capital Management, L.P.	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

One Rockefeller Plaza 32 Nd Floor
New York, NY, 10020